Project Grant R01HD121726
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded a $458,616 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the University of Texas at Dallas, effective September 15, 2025, through August 31, 2027. The award funds research investigating the impact of estrogen hormone therapy modality on urobiome dynamics in postmenopausal women, with emphasis on reducing recurrent urinary tract infections (UTIs). The research...
- Federal Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded The University of Texas Southwestern Medical Center a $249K Project Grant (CFDA 93.865: Child Health and Human Development Extramural Research) on June 15, 2026, for a three-year research initiative extending through May 31, 2029. The grant funds multiscale experimental and computational methods to characterize pregnancy-induced remodeling of pelvic floor muscles (PFMs), with the objective of...
- Federal Grant Award Summary Emory University received a $1.454 million Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective August 1, 2025, through April 30, 2029. The research project, titled "Delineating the Role of ALDH2 in Endometriosis," aims to advance understanding of the molecular mechanisms underlying endometriosis-associated pain and develop...
- Federal Project Grant Award Summary The Trustees of Tufts College received a $351,945 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective June 1, 2026, with completion targeted for February 28, 2031. The award funds research to investigate inflammation resolution mechanisms in endometrial health and disease, specifically examining how specialized...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $682,848 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective June 1, 2026, through February 28, 2031. The award funds research to advance understanding of mitochondrial function and dynamics in reproductive biology and aging. The project develops and applies an innovative...
- Federal Project Grant Award Summary The University of Delaware received a $430,063 Project Grant awarded on August 10, 2025, by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award supports the development of photoacoustic imaging technology to improve endometriosis diagnosis and treatment through August 31, 2027. The research will produce inflammation-targeted nanoparticles...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $246,000 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective September 1, 2025, with a completion date of August 31, 2027. This award funds research investigating pain mechanisms in the female reproductive tract, specifically examining serotonergic and purinergic signaling pathways that mediate...
- Grant Award Summary The University of Texas Southwestern Medical Center received a $456,500 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective June 1, 2026 through May 31, 2028. The award funds research to characterize the molecular mechanisms of human cervical epithelial barrier function during pregnancy. The project delivers two primary research products: (1)...
- Federal Grant Award Summary This $531,368 Project Grant, awarded August 1, 2025, by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), supports basic neuroscience research investigating sex-dependent mechanisms of pain control. Conducted at the University of California, San Francisco, the research employs behavioral pain assessment, hormone replacement studies, mouse...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke awarded a $4.04 million Project Grant to the University of Texas at Dallas for a three-year initiative (September 1, 2025 through August 31, 2028) to identify and validate therapeutic targets for chronic pain treatment. The project leverages a CRISPR-based functional genomic screening platform developed by collaborating researchers at the University of Sydney and an extensive human dorsal root ganglion...
The University of Texas at Dallas received a $608,387 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective July 1, 2026, through March 31, 2031. The award funds research investigating vaginal microbiome-nociceptor interactions in endometriosis pain, with the primary objective of elucidating the bidirectional relationship between the vaginal microbiota and uterine-innervating nerve fibers that express calcitonin gene-related peptide (CGRP). The research employs mouse models of endometriosis combined with microbiota manipulation paradigms—including intravaginal antibiotic treatment, vaginal microbiota transplantation, and probiotic administration—to determine the mechanisms by which the endometriosis-associated microbiome contributes to pain sensitization. The deliverables encompass three primary research aims utilizing chemogenetics and behavioral testing to establish causality in CGRP signaling pathways, characterize microbial-mediated nociceptor activation, and identify specific bacterial metabolites and host factors that perpetuate the endometriosis pain cycle. This project addresses a significant clinical gap, as current surgical interventions (lesion removal and hysterectomy) provide incomplete pain relief in many patients, suggesting additional non-surgical factors warrant investigation. The research is positioned to generate novel insights into pain mechanisms and potentially inform microbiome-based therapeutic interventions for endometriosis management.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $608.4k | 6/30/26 |